Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS

David Price,1,2 William Henley,1,3 José Eduardo Delfini Cançado,4 Leonardo M Fabbri,5 Huib AM Kerstjens,6 Alberto Papi,7 Nicolas Roche,8 Elif Şen,9 Dave Singh,10 Claus F Vogelmeier,11 Elena Nudo,12 Victoria Carter,1 Derek Skinner,1 Rebecca Vella,1 Joan B Soriano,13 Maxim Kots,12 George George...

詳細記述

書誌詳細

主要な著者:	Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G
フォーマット:	Artigo
言語:	Inglês
出版事項:	Dove Medical Press 2024-01-01
シリーズ:	Pragmatic and Observational Research
主題:	inhaled corticosteroids pneumonia copd extrafine beclometasone long-acting bronchodilators
オンライン･アクセス:	https://www.dovepress.com/risk-of-pneumonia-in-patients-with-copd-initiating-fixed-dose-inhaled--peer-reviewed-fulltext-article-POR
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!